A detailed history of Emerald Mutual Fund Advisers Trust transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 574,810 shares of ACAD stock, worth $8.5 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
574,810
Previous 558,849 2.86%
Holding current value
$8.5 Million
Previous $9.08 Million 2.59%
% of portfolio
0.5%
Previous 0.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$15.14 - $19.14 $241,649 - $305,493
15,961 Added 2.86%
574,810 $8.85 Million
Q2 2024

Aug 06, 2024

SELL
$14.62 - $18.42 $10.1 Million - $12.7 Million
-691,380 Reduced 55.3%
558,849 $9.08 Million
Q1 2024

May 08, 2024

SELL
$17.79 - $30.86 $966,477 - $1.68 Million
-54,327 Reduced 4.16%
1,250,229 $23.1 Million
Q4 2023

Feb 05, 2024

BUY
$20.78 - $31.77 $11,803 - $18,045
568 Added 0.04%
1,304,556 $40.8 Million
Q3 2023

Oct 26, 2023

BUY
$20.84 - $33.47 $268,710 - $431,562
12,894 Added 1.0%
1,303,988 $27.2 Million
Q2 2023

Aug 10, 2023

BUY
$17.8 - $25.65 $1.49 Million - $2.15 Million
83,792 Added 6.94%
1,291,094 $30.9 Million
Q1 2023

May 04, 2023

BUY
$16.32 - $20.92 $2.59 Million - $3.32 Million
158,552 Added 15.12%
1,207,302 $22.7 Million
Q4 2022

Feb 03, 2023

BUY
$14.2 - $18.63 $227,356 - $298,284
16,011 Added 1.55%
1,048,750 $16.7 Million
Q3 2022

Oct 25, 2022

BUY
$14.11 - $18.27 $3.75 Million - $4.86 Million
265,768 Added 34.65%
1,032,739 $16.9 Million
Q2 2022

Jul 29, 2022

BUY
$13.01 - $27.22 $1.52 Million - $3.18 Million
116,978 Added 18.0%
766,971 $10.8 Million
Q1 2022

Apr 29, 2022

SELL
$20.94 - $27.5 $1.21 Million - $1.59 Million
-57,976 Reduced 8.19%
649,993 $15.7 Million
Q4 2021

Feb 02, 2022

BUY
$16.79 - $27.09 $11.9 Million - $19.2 Million
707,969 New
707,969 $16.5 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.